Gene · 654
Papers3,545
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,545
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autophagy Is a Crucial Path in Chondrogenesis of Adipose-Derived Mesenchymal Stromal Cells Laden in Hydrogel. | Gels | 2022 | 36547290 | PubTator, text mining | PubMed |
| Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC-derived multipotent cells. | Clin Transl Med | 2022 | 36536500 | PubTator, text mining | PubMed |
| The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma. | Front Pharmacol | 2022 | 36532749 | PubTator, text mining | PubMed |
| Gibberellin derivative GA-13315 overcomes multidrug resistance in breast cancer by up-regulating BMP6 expression. | Front Pharmacol | 2022 | 36532723 | PubTator, text mining | PubMed |
| The impact of SNP density on quantitative genetic analyses of body size traits in a wild population of Soay sheep. | Ecol Evol | 2022 | 36532132 | PubTator, text mining | PubMed |
| Dysregulation of iron metabolism modulators in virologically suppressed HIV-infected patients. | Front Immunol | 2022 | 36505484 | PubTator, text mining | PubMed |
| New Advances in Iron Metabolism, Ferritin and Hepcidin Research. | Int J Mol Sci | 2022 | 36499028 | PubTator, text mining | PubMed |
| The Role of Bone Morphogenetic Protein Receptor Type 2 (BMPR2) and the Prospects of Utilizing Induced Pluripotent Stem Cells (iPSCs) in Pulmonary Arterial Hypertension Disease Modeling. | Cells | 2022 | 36497082 | PubTator, text mining | PubMed |
| Haemochromatosis revisited. | World J Hepatol | 2022 | 36483608 | PubTator, text mining | PubMed |
| Cells, growth factors and biomaterials used in tissue engineering for hair follicles regeneration. | Regen Ther | 2022 | 36475027 | PubTator, text mining | PubMed |
| Nanotopographical cues for regulation of macrophages and osteoclasts: emerging opportunities for osseointegration. | J Nanobiotechnology | 2022 | 36463225 | PubTator, text mining | PubMed |
| Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial. | Nat Med | 2022 | 36456835 | PubTator, text mining | PubMed |
| Neurovascular coupling in bone regeneration. | Exp Mol Med | 2022 | 36446849 | PubTator, text mining | PubMed |
| Myofibroblast specific targeting approaches to improve fibrosis treatment. | Chem Commun (Camb) | 2022 | 36445310 | PubTator, text mining | PubMed |
| Unveiling the transcriptomic landscape and the potential antagonist feedback mechanisms of TGF-β superfamily signaling module in bone and osteoporosis. | Cell Commun Signal | 2022 | 36443839 | PubTator, text mining | PubMed |
| Application of second-generation sequencing in congenital pulmonary airway malformations. | Sci Rep | 2022 | 36443638 | PubTator, text mining | PubMed |
| Hydrogel-based delivery system applied in the local anti-osteoporotic bone defects. | Front Bioeng Biotechnol | 2022 | 36440439 | PubTator, text mining | PubMed |
| Contribution to Bone Formation of the Schneiderian Membrane after Sinus Augmentation: A Histological Study in Rabbits. | Materials (Basel) | 2022 | 36431558 | PubTator, text mining | PubMed |
| Intraoperative Creation of Tissue-Engineered Grafts with Minimally Manipulated Cells: New Concept of Bone Tissue Engineering In Situ. | Bioengineering (Basel) | 2022 | 36421105 | PubTator, text mining | PubMed |
| Heterotopic ossification in primary rectal cancer with squamous cell carcinoma-like differentiation. | Fujita Med J | 2022 | 36415832 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/654/papers?page=27